Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

It's time for an update on the Medical company Grifols, S.A. (NASDAQ:GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

European equities traded in the US as American depositary receipts were edging up 0.1% to 1,415.89 late Thursday morning on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...

Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Grifols, S.A. (NASDAQ:GRFS) delivered strong financial results in Q3 2024, showing solid growth and improved financial health. Revenue reached EUR 1,793 million, reflecting a 12.4% year-over-year ...

And the region overall supports production sites from Thermo Fisher Scientific, Merck, Novo Nordisk, Grifols, Pfizer and Catalent. In a news release Friday, Johnson & Johnson was the latest ...

And the region overall supports production sites from Thermo Fisher Scientific, Merck, Novo Nordisk, Grifols, Pfizer and Catalent. Brian Gordon is the Business & Technology reporter for The News ...

February 27, 2025 Grifols prevé aumentar ingresos y flujo de caja libre, y sus acciones se disparan La farmacéutica española Grifols dijo el jueves que espera que sus ingresos, utilidades ...